Most Popular Stories
- Health IT stimulus includes Medicare EMR incentives
- International study finds U.S. behind in access, quality
- Texas test lab says it may compete with CCHIT
- GE forms $250M health technology investment fund, will debut CDS system at HIMSS
- Epic's Faulkner steals the show at CHIME
- SPOTLIGHT: Up to $850B of healthcare spending is wasteful
Featured Jobs
-
OBGYN Job in Indiana
StaffPointe, LLC - southwest, IN -
Nurse Practitioner or Physician Assistant - Cardiology
AVA Search Group - Northeastern, SD -
Family Practice Job in Indiana
StaffPointe, LLC - near Lawrenceburg, IN -
Family Practice Job for Massachusetts
StaffPointe, LLC - south, MA -
Internal Medicine Job in Florida
StaffPointe, LLC - Fort Lauderdale, FL
Events
- Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT - IHI's 21st Annual National Forum on Quality Improvement in Health Care
December 6-9 — Orlando, FL - Mobile Healthcare Industry Summit
1-2 Dec 09 — London
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Hospital Fires | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
SPOTLIGHT: Are costly cancer drugs worth the price?
With price tags that can hit a mind-boggling $100,000 for an annual supply, critics are increasingly questioning whether certain cancer drugs are worth the price, particularly given that they may only extent a patient's life for a few months. policymakers and clinicians are asking whether society should invest such a large sum on patients who are about to die either way. Article
Related Stories
- Case study: Beth Israel Deaconess uses 'tag' game to boost hand washing
- CMS officials say they want RAC program to be fair
- SPOTLIGHT: Officials consider reasons for steep mammogram drop
- Kaiser suspends perinatologist over mistakes
- Trend: States try to counter pharma drug marketing
- "Behind the counter" non prescription meds considered
- ALSO NOTED: CalPERS cuts $225M deal with BC of California; D.C. retail clinic operator plans area expansion; and much more...
- Hospitals let families, patients activate rapid response
- Wash. state program increases pain med use
- ALSO NOTED: Senators approve CHIP expansion; Bill would give chronically-ill better insurance access; and much more...
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





